Stefan D. Anker

141.6k total citations · 34 hit papers
734 papers, 56.7k citations indexed

About

Stefan D. Anker is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Stefan D. Anker has authored 734 papers receiving a total of 56.7k indexed citations (citations by other indexed papers that have themselves been cited), including 438 papers in Cardiology and Cardiovascular Medicine, 156 papers in Endocrinology, Diabetes and Metabolism and 153 papers in Physiology. Recurrent topics in Stefan D. Anker's work include Heart Failure Treatment and Management (276 papers), Cardiovascular Function and Risk Factors (173 papers) and Nutrition and Health in Aging (113 papers). Stefan D. Anker is often cited by papers focused on Heart Failure Treatment and Management (276 papers), Cardiovascular Function and Risk Factors (173 papers) and Nutrition and Health in Aging (113 papers). Stefan D. Anker collaborates with scholars based in Germany, United States and United Kingdom. Stefan D. Anker's co-authors include Stephan von Haehling, Andrew J.S. Coats, Piotr Ponikowski, Gerasimos Filippatos, Wolfram Doehner, John E. Morley, Philip A. Poole‐Wilson, Mathias Rauchhaus, Bertram Pitt and Javed Butler and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Stefan D. Anker

709 papers receiving 55.3k citations

Hit Papers

Frailty Consensus: A Call to Action 1997 2026 2006 2016 2013 2020 2006 2009 2010 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Frailty Consensus: A Call to Action
    2013 2.7k citations Stefan D. Anker, Wolfram Doehner et al. profile →
  2. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    2020 1.5k citations Stefan D. Anker et al. profile →
  3. The Seattle Heart Failure Model
    2006 1.5k citations Stefan D. Anker, Milton Packer et al. Circulation profile →
  4. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
    2009 1.4k citations Stefan D. Anker, Josep Comín Colet et al. profile →
  5. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”
    2010 1.2k citations Stefan D. Anker et al. profile →
  6. Heart Failure: Preventing Disease and Death Worldwide
    2014 936 citations Piotr Ponikowski, Stefan D. Anker et al. profile →
  7. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
    2020 831 citations Faı̈ez Zannad, João Pedro Ferreira et al. profile →
  8. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
    2014 821 citations Piotr Ponikowski, Dirk J. van Veldhuisen et al. European Heart Journal profile →
  9. State of the Science
    2009 765 citations Stefan D. Anker et al. Circulation profile →
  10. Endotoxin and immune activation in chronic heart failure: a prospective cohort study
    1999 686 citations Mathias Rauchhaus, Andrew J.S. Coats et al. profile →
  11. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
    2000 673 citations Mathias Rauchhaus, Wolfram Doehner et al. Circulation profile →
  12. Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia
    1997 641 citations Stefan D. Anker, Piotr Ponikowski et al. Circulation profile →
  13. An overview of sarcopenia: facts and numbers on prevalence and clinical impact
    2010 621 citations Stephan von Haehling, Stefan D. Anker et al. profile →
  14. Epidemiology and One-Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid-Range and Reduced Ejection Fraction: An Analysis of The ESC Heart Failure Long-Term Registry
    2017 588 citations Mitja Lainščak, Petar Seferović et al. European Journal of Heart Failure profile →
  15. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    2021 578 citations Gerasimos Filippatos, Stefan D. Anker et al. European Heart Journal profile →
  16. Mitochondrial function as a therapeutic target in heart failure
    2016 562 citations John G.F. Cleland, Javed Butler et al. profile →
  17. Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure
    2011 513 citations Friedrich Koehler, Sebastian Winkler et al. Circulation profile →
  18. Altered Intestinal Function in Patients With Chronic Heart Failure
    2007 501 citations Anja Sandek, Stephan von Haehling et al. profile →
  19. Heart failure and kidney dysfunction: epidemiology, mechanisms and management
    2016 463 citations Gerasimos Filippatos, Stefan D. Anker et al. profile →
  20. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
    2019 458 citations Brendan M. Everett, Jan H. Cornel et al. Circulation profile →
  21. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014
    2014 444 citations Stefan D. Anker, Stephan von Haehling et al. profile →
  22. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
    2017 302 citations Dirk J. van Veldhuisen, Piotr Ponikowski et al. Circulation profile →
  23. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
    2016 299 citations Gerasimos Filippatos, Stefan D. Anker et al. European Heart Journal profile →
  24. Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis
    2017 291 citations Stefan D. Anker, Bridget‐Anne Kirwan et al. European Journal of Heart Failure profile →
  25. Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure
    2017 269 citations Milton Packer, Stefan D. Anker et al. profile →
  26. Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction
    2020 266 citations Milton Packer, Stefan D. Anker et al. Circulation profile →
  27. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
    2020 243 citations Stefan D. Anker, Javed Butler et al. Circulation profile →
  28. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
    2021 226 citations Milton Packer, Javed Butler et al. Circulation profile →
  29. Trends in 30- and 90-Day Readmission Rates for Heart Failure
    2021 156 citations Stephen J. Greene, Stefan D. Anker et al. profile →
  30. Iron deficiency and cardiovascular disease
    2022 108 citations Stephan von Haehling, Javed Butler et al. European Heart Journal profile →
  31. SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
    2023 75 citations Khawaja M. Talha, Stefan D. Anker et al. PubMed profile →
  32. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis
    2023 67 citations Piotr Ponikowski, Adrian F. Hernandez et al. European Heart Journal profile →
  33. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
    2024 45 citations Stefan D. Anker, Adrian F. Hernandez et al. profile →
  34. Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
    2025 13 citations Stefan D. Anker, Javed Butler et al. profile →

Peers

Stefan D. Anker
Comparison fields: 5 of 192
  • Cardiology and Cardiovascular Medicine 27.4k
  • Physiology 13.0k
  • Molecular Biology 9.2k
  • Endocrinology, Diabetes and Metabolism 8.9k
  • Pulmonary and Respiratory Medicine 7.5k
Replace Thomas F. Lüscher with:
Thomas F. Lüscher Switzerland
Bruce M. Psaty United States
Martin G. Larson United States
Piotr Ponikowski Poland
Andrew J.S. Coats United Kingdom
Aaron R. Folsom United States
Scott D. Solomon United States
Ramachandran S. Vasan United States
Gregg C. Fonarow United States
Dirk J. van Veldhuisen Netherlands
Thomas F. Lüscher Switzerland View profile →
Citations per field, relative to Stefan D. Anker
Stefan D. Anker · 1×
Citations per year, relative to Stefan D. Anker
Stefan D. Anker · 1×

Countries citing papers authored by Stefan D. Anker

Since Specialization
Citations

This map shows the geographic impact of Stefan D. Anker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan D. Anker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan D. Anker more than expected).

Fields of papers citing papers by Stefan D. Anker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan D. Anker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan D. Anker. The network helps show where Stefan D. Anker may publish in the future.

Co-authorship network of co-authors of Stefan D. Anker

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan D. Anker. A scholar is included among the top collaborators of Stefan D. Anker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan D. Anker. Stefan D. Anker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials
2025 ·Diabetes Obesity and Metabolism ·João Pedro Ferreira, Pedro Marques, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Abhinav Sharma, Francisco Vasques‐Nóvoa, (unknown), João Sérgio Neves, Milton Packer, (unknown)
0
2
Body Mass Index and Cardiorenal Outcomes in the EMPEROR-Preserved Trial: Principal Findings and Meta-Analysis with the DELIVER Trial
2024 ·European Journal of Heart Failure ·Naveed Sattar, Javed Butler, Matthew M.Y. Lee, Josephine Harrington, Abhinav Sharma, Faı̈ez Zannad, Gerasimos Filippatos, Subodh Verma, James L. Januzzi, João Pedro Ferreira, Stuart Pocock, Egon Pfarr, Anne Pernille Ofstad, Martina Brueckmann, Milton Packer, Stefan D. Anker
15
3
SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence breakdown →
2023 ·PubMed ·Khawaja M. Talha, Stefan D. Anker, Javed Butler
75
4
Albuminuria as a marker of systemic congestion in patients with heart failure
2022 ·European Heart Journal ·Eva M. Boorsma, Jozine M. ter Maaten, Kevin Damman, (unknown), Faı̈ez Zannad, Dirk J. van Veldhuisen, Nilesh J. Samani, Kenneth Dickstein, Marco Metra, Gerasimos Filippatos, Chim C. Lang, Leong L. Ng, Stefan D. Anker, John G.F. Cleland, Pierpaolo Pellicori, Ron T. Gansevoort, Hiddo J.L. Heerspink, Adriaan A. Voors, Johanna E. Emmens
39
5
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure breakdown →
2019 ·Circulation ·Brendan M. Everett, Jan H. Cornel, Mitja Lainščak, Stefan D. Anker, Antonio Abbate, Tom Thurén, Peter Libby, Robert J. Glynn, Paul M. Ridker
458
6
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency breakdown →
2017 ·Circulation ·Dirk J. van Veldhuisen, Piotr Ponikowski, Peter van der Meer, Marco Metra, Michael Böhm, Artem Doletsky, Adriaan A. Voors, Iain C. Macdougall, Stefan D. Anker, Bernard Roubert, Lorraine Zakin, Alain Cohen‐Solal
302
7
Steps Forward in Regulatory Pathways for Acute and Chronic Heart failure
2015 ·European Journal of Heart Failure ·Luca Pani, S. Pecorelli, Giuseppe Rosano, Stefan D. Anker, Andrea Peracino, Laura Fregonese, Krishna Prasad, Guido Rasi
7
8
Insulin Resistance in Heart Failure: Differences Between Patients with Reduced and Preserved Left Ventricular Ejection Fraction
2015 ·European Journal of Heart Failure ·Nadja Scherbakov, (unknown), Anja Sandek, Tibor Szabó, Agnieszka Töpper, Ewa A. Jankowska, Jochen Springer, Stephan von Haehling, Stefan D. Anker, Mitja Lainščak, Stefan Engeli, Hans‐Dirk Düngen, Wolfram Doehner
37
9
In-Hospital Worsening Heart Failure
2015 ·European Journal of Heart Failure ·Javed Butler, Mihai Gheorghiade, Anita A. Kelkar, Gregg C. Fonarow, Stefan D. Anker, Stephen J. Greene, L. Papadimitriou, Sean P. Collins, Frank Ruschitzka, Clyde W. Yancy, John R. Teerlink, Kirkwood F. Adams, Gad Cotter, Piotr Ponikowski, G. Michael Felker, Marco Metra, Gerasimos Filippatos
44
10
Heart Failure Association of the European Society of Cardiology Specialist Heart Failure Curriculum
2014 ·European Journal of Heart Failure ·Theresa A. McDonagh, Roy S. Gardner, Mitja Lainščak, Olav Wendelboe Nielsen, John Parissis, Gerasimos Filippatos, Stefan D. Anker
30
11
Cardiopulmonary Exercise Testing in Systolic Heart Failure in 2014: The Evolving Prognostic Role
2014 ·European Journal of Heart Failure ·Ugo Corrà, Massimo Piepoli, Stamatis Adamopoulos, Piergiuseppe Agostoni, Andrew J.S. Coats, Viviane M. Conraads, Ekaterini Lambrinou, Burkert Pieske, Ewa Piotrowicz, Jean‐Paul Schmid, Petar Seferović, Stefan D. Anker, Gerasimos Filippatos, Piotr Ponikowski
70
12
Increased Catabolic Activity in Adipose Tissue of Patients with Chronic Heart Failure
2013 ·European Journal of Heart Failure ·Tibor Szabó, (unknown), Anja Mähler, Thomas Kung, (unknown), Stephan von Haehling, Stefan D. Anker, Michael Boschmann, Wolfram Doehner
42
13
Intravenous Ferric Carboxymaltose in Iron-Deficient Chronic Heart Failure Patients with and Without Anaemia: a Subanalysis of the FAIR-HF Trial
2013 ·European Journal of Heart Failure ·Gerasimos Filippatos, Dimitrios Farmakis, Josep Comín Colet, Kenneth Dickstein, Thomas F. Lüscher, Ronnie Willenheimer, John Parissis, (unknown), Claudio Mori, B. Rothe, Nicola Greenlaw, Ian Ford, Piotr Ponikowski, Stefan D. Anker
111
14
The Effect of Intravenous Ferric Carboxymaltose on Red Cell Distribution Width: A Subanalysis of the FAIR-HF Study
2013 ·European Journal of Heart Failure ·Emeline M. Van Craenenbroeck, Viviane M. Conraads, Nicola Greenlaw, (unknown), Claudio Mori, Piotr Ponikowski, Stefan D. Anker
25
15
Effect of Oral Digoxin in High-Risk Heart Failure Patients: A Pre-Specified Subgroup Analysis of the DIG Trial
2013 ·European Journal of Heart Failure ·Mihai Gheorghiade, Kanan Patel, Gerasimos Filippatos, Stefan D. Anker, Dirk J. van Veldhuisen, John G.F. Cleland, Marco Metra, Inmaculada Aban, Stephen J. Greene, Kirkwood F. Adams, John J.V. McMurray, Ali Ahmed
69
16
Troponin I in Acute Decompensated Heart Failure: Insights from the ASCEND-HF Study
2012 ·European Journal of Heart Failure ·G. Michael Felker, Vic Hasselblad, W.H. Wilson Tang, Adrian F. Hernandez, Paul W. Armstrong, Gregg C. Fonarow, Adriaan A. Voors, Marco Metra, John J.V. McMurray, Javed Butler, Gretchen Heizer, Kenneth Dickstein, Barry M. Massie, Dan Atar, Richard W. Troughton, Stefan D. Anker, Robert M. Califf, Randall C. Starling, Christopher M. O’Connor
87
17
Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure breakdown →
2011 ·Circulation ·Friedrich Koehler, Sebastian Winkler, Michael Schieber, Udo Sechtem, Karl Stangl, Michael Böhm, H. Boll, Gert Baumann, Marcus Honold, Kerstin Koehler, Goetz Gelbrich, Bridget‐Anne Kirwan, Stefan D. Anker
513
18
Changes in Exercise Capacity, Ventilation, and Body Weight Following Heart Transplantation
2006 ·European Journal of Heart Failure ·Dirk Habedank, Ralf Ewert, Manfred Hummel, Roland Wensel, Roland Hetzer, Stefan D. Anker
22
19
Reduced Peripheral Skeletal Muscle Mass and Abnormal Reflex Physiology in Chronic Heart Failure
2006 ·Circulation ·Massimo Piepoli, Agnieszka Kaczmarek, Dárrel P. Francis, Ceri Davies, Mathias Rauchhaus, Ewa A. Jankowska, Stefan D. Anker, Alessandro Capucci, Waldemar Banasiak, Piotr Ponikowski
128
20
Studies on Intragastric PCO2 at Rest and During Exercise as a Marker of Intestinal Perfusion in Patients with Chronic Heart Failure
2004 ·European Journal of Heart Failure ·Andreas Krack, Barbara M. Richartz, (unknown), (unknown), Ulrich Lotze, Stefan D. Anker, Hans R. Figulla
67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas F. Lüscher Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by Piotr Ponikowski Breakdown of academic impact, for papers by Andrew J.S. Coats Breakdown of academic impact, for papers by Aaron R. Folsom Breakdown of academic impact, for papers by Scott D. Solomon Breakdown of academic impact, for papers by Ramachandran S. Vasan Breakdown of academic impact, for papers by Gregg C. Fonarow Breakdown of academic impact, for papers by Dirk J. van Veldhuisen
Rankless by CCL
2026